Literature DB >> 15592506

PKC theta mediates pre-TCR signaling and contributes to Notch3-induced T-cell leukemia.

Maria Pia Felli1, Alessandra Vacca, Angelica Calce, Diana Bellavia, Antonio F Campese, Rita Grillo, Monica Di Giovine, Saula Checquolo, Claudio Talora, Rocco Palermo, Giuseppina Di Mario, Luigi Frati, Alberto Gulino, Isabella Screpanti.   

Abstract

Protein kinase (PK)C theta is a critical regulator of mature T-cell activation and proliferation, being implicated in TCR-triggered nuclear factor (NF)-kappa B activation and providing important survival signals to leukemic T cells. We previously showed that overexpression of pT alpha/pre-TCR and constitutive activation of NF-kappa B characterize the T-cell leukemia/lymphoma developing in Notch3-IC transgenic mice. We report here that PKC theta is a downstream target of Notch3 signaling and that its activation and membrane translocation require a functional pre-TCR in order to trigger NF-kappa B activation in thymocytes and lymphoma cells of transgenic mice. Furthermore, deletion of PKC theta in Notch3-IC transgenic mice reduces the incidence of leukemia, correlating with decreased NF-kappa B activation. This paper therefore suggests that PKC theta mediates the activation of NF-kappa B by pre-TCR in immature thymocytes and contributes to the development of Notch3-dependent T-cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15592506     DOI: 10.1038/sj.onc.1208302

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

Review 1.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

2.  Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia.

Authors:  Steven M Chan; Andrew P Weng; Robert Tibshirani; Jon C Aster; Paul J Utz
Journal:  Blood       Date:  2007-03-15       Impact factor: 22.113

Review 3.  The Role of Notch3 in Cancer.

Authors:  Zviadi Aburjania; Samuel Jang; Jason Whitt; Renata Jaskula-Stzul; Herbert Chen; J Bart Rose
Journal:  Oncologist       Date:  2018-04-05

4.  PKCθ activation in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters and growth factors is needed for stimulation of numerous important cellular signaling cascades.

Authors:  Veronica Sancho; Marc J Berna; Michelle Thill; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2011-07-23

5.  Protein kinase C-theta is required for efficient positive selection.

Authors:  Sharon Celeste Morley; K Scott Weber; Henry Kao; Paul M Allen
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 6.  Transcription factors and target genes of pre-TCR signaling.

Authors:  Cristina López-Rodríguez; Jose Aramburu; Rosa Berga-Bolaños
Journal:  Cell Mol Life Sci       Date:  2015-02-22       Impact factor: 9.261

7.  Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL.

Authors:  Yongzhi Cui; Masahiro Onozawa; Haven R Garber; Leigh Samsel; Ziyao Wang; J Philip McCoy; Sandra Burkett; Xiaolin Wu; Peter D Aplan; Crystal L Mackall
Journal:  Blood       Date:  2015-03-26       Impact factor: 22.113

8.  Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis.

Authors:  D Juskevicius; T Lorber; J Gsponer; V Perrina; C Ruiz; F Stenner-Liewen; S Dirnhofer; A Tzankov
Journal:  Leukemia       Date:  2016-05-20       Impact factor: 11.528

Review 9.  Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia.

Authors:  Teresa Palomero; Adolfo Ferrando
Journal:  Clin Lymphoma Myeloma       Date:  2009

10.  A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.

Authors:  Katherine Bessette; Mark L Lang; Roy A Fava; Martin Grundy; Jennifer Heinen; Laurie Horne; Rosanne Spolski; Amin Al-Shami; Herbert C Morse; Warren J Leonard; John A Kelly
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.